146 results on '"Lim, Darren Wan-Teck"'
Search Results
2. A Phase 1b/2 Study of Alpelisib in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
3. Matrisomics: Beyond the extracellular matrix for unveiling tumor microenvironment
4. Correction: Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer
5. Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer
6. Clinical efficacy and biomarker analysis of dual PD-1/CTLA-4 blockade in recurrent/metastatic EBV-associated nasopharyngeal carcinoma
7. Elucidating the Function of MAMDC2 in Head and Neck Squamous Cell Carcinoma
8. Elucidating the Role of MAMDC2 in Head and Neck Squamous Cancer
9. Efficacy of Anti-PD1 Blockade in Treating Recurrent or Metastatic Nasopharyngeal Cancer: A Systematic Review and Meta-analysis
10. International recommendations for plasma Epstein-Barr virus DNA measurement in nasopharyngeal carcinoma in resource-constrained settings: lessons from the COVID-19 pandemic
11. Effect of tumor-immune microenvironment (TIME) on disparate ascending (A) and descending (D) subtypes of nasopharyngeal carcinoma (NPC).
12. MicroRNA-Profiling Based Screening of Non-small-cell Lung Cancer in Plasma
13. High-Throughput Microfluidic Extraction of Platelet-free Plasma for MicroRNA and Extracellular Vesicle Analysis
14. Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations
15. CYP2A6 Genetic Polymorphism and Nicotine Metabolism of Male Smokers in Indonesia.
16. Combinatorial hypofractionated radiotherapy and pembrolizumab in anaplastic thyroid cancer
17. Heterogeneity of PD-L1 expression among resected EGFR-mutated NSCLC and prognostic implications.
18. Identifying correlates of post treatment responses for unresectable locally advanced non-small cell lung cancer (LA NSCLC).
19. Association of Claudin-1 overexpression with immune exclusion in nasopharyngeal carcinoma and its potential as a novel therapeutic target.
20. Molecular testing in non-small cell lung cancer: A consensus recommendation
21. Dearth of smoking-induced mutations in NSRO-driven non-small-cell lung cancer despite smoking exposure
22. Diverse Resistant Mechanisms Identified Using Serial Next-Generation Sequencing in a Patient With ALK-Rearranged Metastatic Lung Adenocarcinoma: A Case Report
23. Response to fam-Trastuzumab-Deruxtecan in patients with metastatic HER2-positive salivary duct carcinoma: A case series
24. Circulating Biomarkers for Prediction of Immunotherapy Response in NSCLC
25. Is There a Unicorn Among the Uncommon EGFR Mutations?
26. Profile of Exon 20 T790M Mutation Incidence Rate with Plasma ctDNA in Lung Adenocarcinoma Patients Receiving EGFR-TKI Treatment
27. Real world efficacy of osimertinib in second line/beyond in patients with metastatic EGFR+ non-small cell lung cancer and role of paired tumour-plasma T790M testing at tyrosine kinase inhibitor resistance
28. Multidisciplinary lung cancer clinic: An emerging model of care
29. Dietary factors and the risk of lung cancer by epidermal growth factor receptor mutation status and histological subtypes
30. Immunotherapy with chemotherapy and anti-angiogenic therapy for EGFR mutated NSCLC: challenging the dogma
31. Successful targeting of PD-1/PD-L1 with chimeric antigen receptor-natural killer cells and nivolumab in a humanized mouse cancer model
32. Referee report. For: The role of oncogenes and tumor suppressor genes in determining survival rates of lung cancer patients in the population of North Sumatra, Indonesia [version 2; peer review: 2 approved]
33. A phase 1b/2 study of nanatinostat and valganciclovir in patients with advanced Epstein-Barr virus positive (EBV+) solid tumors and in combination with pembrolizumab in patients with recurrent/metastatic nasopharyngeal carcinoma (RM-NPC).
34. Erytheme au site d'une cicatrice du vaccin bacille de Calmette-Guerin apres l'obtention d'une dose du vaccin a ARN messager contre le SRAS-CoV-2
35. Immunotherapy with chemotherapy and anti-angiogenic therapy for EGFR mutated NSCLC: challenging the dogma.
36. Matrisomal genes in squamous cell carcinoma of head and neck influence tumor cell motility and response to cetuximab treatment
37. A First-in-Human, Phase I, Multicenter, Open-Label, Dose-Escalation Study of PCA062: An Antibody–Drug Conjugate Targeting P-Cadherin, in Patients With Solid Tumors
38. Referee report. For: The role of oncogenes and tumor suppressor genes in determining survival rates of lung cancer patients in the population of North Sumatra, Indonesia [version 1; peer review: 1 approved, 1 approved with reservations]
39. The case for better hospitalisation selection in cancer patients
40. Bacillus Calmette–Guérin scar flare after an mRNA SARS-CoV-2 vaccine
41. Abstract CT286: CANOPY program clinical trials: Canakinumab (Cana) in patients (pts) with non-small cell lung cancer (NSCLC)
42. Abstract CT203: A phase II trial of ipilimumab in combination with nivolumab in EBV-associated advanced nasopharyngeal carcinoma (NCT03097939)
43. Abstract 5060: Establishment and characterization of humanized mouse NPC-PDX model for testing immunotherapy
44. Abstract CT171: Phase I study of BLZ945 alone and with spartalizumab (PDR001) in patients (pts) with advanced solid tumors
45. Establishment and Characterization of Humanized Mouse NPC-PDX Model for Testing Immunotherapy
46. Association of clinical factors with survival outcomes in laryngeal squamous cell carcinoma (LSCC)
47. Matrisomal abnormality: a predictive biomarker for cancer immunotherapy
48. Detection and prognostic relevance of circulating tumour cells (CTCs) in Asian breast cancers using a label-free microfluidic platform
49. Abstract CT150: Phase II study of spartalizumab (PDR001) vs chemotherapy (CT) in patients with recurrent/metastatic nasopharyngeal cancer (NPC)
50. The CANOPY program: Canakinumab in patients (pts) with non-small cell lung cancer (NSCLC).
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.